Skip to main content

. 1968 Aug 24;3(5616):498. doi: 10.1136/bmj.3.5616.498-a

Oral fibrinolytic agents.

G R Fearnley, R Chakrabarti

PMCID: PMC1986408 PMID: 5666808

498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CHAKRABARTI R., HOCKING E. D., FEARNLEY G. R. FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE. Lancet. 1965 Aug 7;2(7406):256–259. doi: 10.1016/s0140-6736(65)92383-4. [DOI] [PubMed] [Google Scholar]
Chakrabarti R., Fearnley G. R. Reduction of platelet stickiness by phenformin plus ethyloestrenol. Lancet. 1967 Nov 11;2(7524):1012–1014. doi: 10.1016/s0140-6736(67)90287-5. [DOI] [PubMed] [Google Scholar]
Chakrabarti R., Hocking E. D., Fearnley G. R., Mann R. D., Attwell T. N., Jackson D. Fibrinolytic activity and coronary-artery disease. Lancet. 1968 May 11;1(7550):987–990. doi: 10.1016/s0140-6736(68)91104-5. [DOI] [PubMed] [Google Scholar]
FEARNLEY G. R., CHAKRABARTI R. PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD. J Clin Pathol. 1964 May;17:328–332. doi: 10.1136/jcp.17.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
Fearnley G. R., Chakrabarti R., Hocking E. D. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease. Lancet. 1967 Nov 11;2(7524):1008–1011. doi: 10.1016/s0140-6736(67)90286-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES